Beam Therapeutics
BEAM
BEAM
230 hedge funds and large institutions have $5.85B invested in Beam Therapeutics in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 85 increasing their positions, 43 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
11% more funds holding
Funds holding: 208 → 230 (+22)
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
3.77% more ownership
Funds ownership: 68.91% → 72.68% (+3.8%)
Holders
230
Holding in Top 10
11
Calls
$72.3M
Puts
$40.6M
Top Buyers
| 1 | +$217M | |
| 2 | +$117M | |
| 3 | +$26M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$22M |
| 5 |
Two Sigma Investments
New York
|
+$17.2M |
Top Sellers
| 1 | -$61.8M | |
| 2 | -$29.2M | |
| 3 | -$21.7M | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$21.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$17.5M |